Erika Ross, PhD Director, R&D Applied Research

Erika is the Director of R&D Applied Research at Abbott Neuromodulation, leading applied research strategy, external partnerships, portfolio, and execution. Applied research includes computational modeling, pre-clinical, clinical feasibility & safety trials that feed new products and indications. Prior to her role at Abbott, Erika was the Neuroscience Director at Cala Health, a Stanford Biodesign-incubated Bay Area start-up that developed a non-invasive, digitally-enabled neuromodulation solution for Essential Tremor patients. She held roles of increasing leadership at Cala Health as the company completed development and prepared for commercialization. Prior to Cala Health, Erika held the roles of Assistant Professor of Neurologic Surgery and Deputy Director of the Surgical Device Innovation Accelerator at the Mayo Clinic in Rochester, Minnesota where she developed invasive and non-invasive solutions for unmet needs in the neuromodulation and other surgical practice areas.